JAAQ secures $17 million to incorporate clinically approved mental health content.

      The London-based platform, which currently serves 1.5 million eligible lives through enterprise and healthcare initiatives, is utilizing its Series A funding to expedite its entry into the US market and enhance its clinical infrastructure, appointing a new CEO who previously sold his company to Adobe.

      JAAQ, the digital health engagement platform based in London, has secured $17 million in a Series A funding round. This investment comes from Meridian Health Ventures, Fuel Ventures, Bolt Angels, and Guinness Ventures, with the funds intended for scaling partnerships within enterprises, strengthening clinical infrastructure, and expanding into the United States. Dr. Pooja Sikka, a partner at Meridian Health Ventures, has joined the company's board as part of this agreement.

      Founded in 2021 with a direct-to-consumer model focused on video-based mental health content, the company has shifted towards an enterprise and healthcare approach, embedding its library of over 10,000 clinically reviewed videos into the digital offerings of insurers, employers, and healthcare organizations, rather than targeting individual users directly.

      The underlying strategy is structural: instead of requiring individuals to search for a mental health platform, JAAQ integrates its content within the applications and services that users already utilize. Currently, it serves over 1.5 million eligible lives through active enterprise deployments.

      Alex Packham has been appointed as CEO to guide the company into its next phase. He is recognized for founding ContentCal, a social media management SaaS platform that he sold to Adobe in December 2021, and subsequently spent three years overseeing the product's integration into Adobe before leaving the company.

      The platform's commercial model has two components. Organizations can license content from JAAQ’s library to incorporate into their own product experiences, or they can license a customized hosted version of JAAQ.

      Additionally, the company is developing what it calls a “clinical engagement layer” for AI-native products, allowing any digital product or team to integrate regulated mental health content into user experiences without needing to establish their own clinical governance structures.

      JAAQ's proposal to enterprises addresses two concurrent issues: the mental health access gap and the low engagement levels with wellness benefits that organizations invest in but employees seldom utilize.

      The focus on clinical governance is key to how JAAQ sets itself apart from generic AI wellness tools. The platform's content is developed within a defined clinical and creative framework, rather than being generated on demand. The appointment of Johri aims to reinforce the notion that clinical credibility is an inherent part of the product, rather than an afterthought.

      Meridian Health Ventures, which specifically emphasizes UK health tech with a pathway to the US market, aligns well with this positioning. The firm operates the first NHS-anchored venture fund and has a dedicated Innovations in Mental Health Fund.

      The funding is primarily aimed at facilitating US expansion. The UK market has already provided validation; the company's website highlights case studies such as a UK bank that saved £896,000 through improvements in employee productivity and wellbeing, and an insurer that effectively eliminated the equivalent of twelve full-time customer service positions through content delivered by JAAQ.

      Translating this approach into the US employer and health insurer market, where mental health benefits are increasingly prioritized at the board level but engagement remains a challenge, represents the next significant test.